Article info
PDFEthics
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process
- Professor M Schlander, PO Box 1107, D-65741 Eschborn, Germany; michael.schlander{at}innoval-hc.com
Citation
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process
Publication history
- Received May 25, 2007
- Revised August 22, 2007
- Accepted September 4, 2007
- First published June 30, 2008.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group Ltd and the Institute of Medical Ethics
Other content recommended for you
- Value assessment frameworks: who is valuing the care in healthcare?
- Audit of data redaction practices in NICE technology appraisals from 1999 to 2019
- National Institute for Health and Clinical Excellence appraisal and ageism
- Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting
- NICE is dead; long live NICE
- NICE and neurology
- Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006
- Justice and the NICE approach
- Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance
- Diagnosis and management of the epilepsies in children: a summary of the partial update of the 2012 NICE epilepsy guideline